Literature DB >> 20127250

Is atrial fibrillation associated with poor outcome after thrombolysis?

Daniel Sanák1, Roman Herzig, Michal Král, Andrea Bártková, Jana Zapletalová, Martin Hutyra, David Skoloudík, Ivanka Vlachová, Tomás Veverka, David Horák, Petr Kanovský.   

Abstract

Atrial fibrillation (AF) is considered a predictor for severe stroke and poor outcome. The aim was to evaluate whether AF is associated with poor outcome in acute ischemic stroke (IS) patients treated with intravenous thrombolysis (IVT). In a retrospective study, 157 consecutive IS patients (98 males, mean age 67.3 +/- 10.2 years), treated with IVT within 3 hours from stroke onset, were divided into two groups according to presence/absence of AF. Neurological deficit was evaluated using the NIHSS on admission, 24 hours, and 7 days later, while the 90-day clinical outcome was assessed using the modified Rankin Scale (mRS). A total of 66 patients (38 males) presented with AF. The baseline NIHSS was 13.3 +/- 5.4 in AF and 11.0 +/- 5.1 points in non-AF patients (P = 0.006). AF patients had arterial occlusions more frequently in the baseline MRA (54.5% in AF versus 25.3% in non-AF, P = 0.0002). No differences were found between groups in clinical improvement after 24 hours and 7 days or in rate of achieved recanalizations. AF patients had significantly poorer 90-day clinical outcome than non-AF patients (median mRS 2.5 vs. 1.0). Patients with AF had significantly worse 90-day clinical outcome after IVT compared to those without AF, probably due to more severe baseline neurological deficits and the greater number of arterial occlusions in the MRA before IVT.

Entities:  

Mesh:

Year:  2010        PMID: 20127250     DOI: 10.1007/s00415-010-5452-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  28 in total

1.  European Stroke Initiative Recommendations for Stroke Management-update 2003.

Authors:  Tom Skyhoj Olsen; Peter Langhorne; Hans Christoph Diener; Michael Hennerici; Jose Ferro; Johani Sivenius; Nils Gunnar Wahlgren; Philip Bath
Journal:  Cerebrovasc Dis       Date:  2003       Impact factor: 2.762

2.  Impact of diffusion-weighted MRI-measured initial cerebral infarction volume on clinical outcome in acute stroke patients with middle cerebral artery occlusion treated by thrombolysis.

Authors:  Daniel Sanák; Vladimír Nosál'; David Horák; Andrea Bártková; Kamil Zelenák; Roman Herzig; Jirí Bucil; David Skoloudík; Stanislav Burval; Viera Cisariková; Ivanka Vlachová; Martin Köcher; Jana Zapletalová; Egon Kurca; Petr Kanovský
Journal:  Neuroradiology       Date:  2006-08-29       Impact factor: 2.804

3.  Atrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke.

Authors:  K Kimura; K Minematsu; T Yamaguchi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

4.  Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction.

Authors:  Lars Køber; Karl Swedberg; John J V McMurray; Marc A Pfeffer; Eric J Velazquez; Rafael Diaz; Aldo P Maggioni; Viatcheslav Mareev; Grzegorz Opolski; Frans Van de Werf; Faiez Zannad; Georg Ertl; Scott D Solomon; Steven Zelenkofske; Jean-Lucien Rouleau; Jeffrey D Leimberger; Robert M Califf
Journal:  Eur J Heart Fail       Date:  2006-02-28       Impact factor: 15.534

5.  Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial.

Authors:  M R Frankel; L B Morgenstern; T Kwiatkowski; M Lu; B C Tilley; J P Broderick; R Libman; S R Levine; T Brott
Journal:  Neurology       Date:  2000-10-10       Impact factor: 9.910

6.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

7.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

8.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

Authors:  W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas
Journal:  Lancet       Date:  1998-10-17       Impact factor: 79.321

Review 9.  Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review.

Authors:  Joy Liao; Zahira Khalid; Ciaran Scallan; Carlos Morillo; Martin O'Donnell
Journal:  Stroke       Date:  2007-09-27       Impact factor: 7.914

10.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.

Authors:  W M Feinberg; J L Blackshear; A Laupacis; R Kronmal; R G Hart
Journal:  Arch Intern Med       Date:  1995-03-13
View more
  15 in total

1.  Endovascular mechanical recanalization of acute ischaemic stroke in octogenarians.

Authors:  Erasmia Broussalis; F Weymayr; W Hitzl; A F Unterrainer; E Trinka; M Killer
Journal:  Eur Radiol       Date:  2015-09-15       Impact factor: 5.315

2.  Factors Associated with Thrombolysis Outcome in Ischemic Stroke Patients with Atrial Fibrillation.

Authors:  Qiuyun Zhao; Xiaobo Li; Wanli Dong; Min Ye; Yongjun Cao; Meijuan Zhang; Qiantao Cheng; Junshan Zhou; Guofang Chen; Ming Yu; Shanshan Hong; Xiue Wei; Bei Wang; Guiyun Cui; Peng Zhang; Hong Ding; Rongzhen Xu; Yan Chen; Yun Xu
Journal:  Neurosci Bull       Date:  2016-03-07       Impact factor: 5.203

3.  Outcome of patients with atrial fibrillation after intravenous thrombolysis for cerebral ischaemia.

Authors:  Visnja Padjen; Marie Bodenant; Dejana R Jovanovic; Nelly Ponchelle-Dequatre; Novak Novakovic; Charlotte Cordonnier; Ljiljana Beslac-Bumbasirevic; Didier Leys
Journal:  J Neurol       Date:  2013-09-26       Impact factor: 4.849

4.  Predictors for Intracranial Hemorrhage Following Intravenous Thrombolysis in Posterior Circulation Stroke.

Authors:  Tomáš Dorňák; Michal Král; Zuzana Sedláčková; Daniel Šaňák; Eva Čecháková; Petra Divišová; Jana Zapletalová; Petr Kaňovský
Journal:  Transl Stroke Res       Date:  2018-01-15       Impact factor: 6.829

Review 5.  Atrial Fibrillation is Associated With Poor Outcomes in Thrombolyzed Patients With Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.

Authors:  Rongzheng Yue; Dongze Li; Jing Yu; Shuangshuang Li; Yan Ma; Songmin Huang; Zhi Zeng; Rui Zeng; Xiaolin Sun
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

6.  Towards personalised intra-arterial treatment of patients with acute ischaemic stroke: a study protocol for development and validation of a clinical decision aid.

Authors:  Maxim J H L Mulder; Esmee Venema; Bob Roozenbeek; Joseph P Broderick; Sharon D Yeatts; Pooja Khatri; Olvert A Berkhemer; Yvo B W E M Roos; Charles B L M Majoie; Robert J van Oostenbrugge; Wim H van Zwam; Aad van der Lugt; Ewout W Steyerberg; Diederik W J Dippel; Hester F Lingsma
Journal:  BMJ Open       Date:  2017-03-22       Impact factor: 2.692

7.  Not only the Sugar, Early infarct sign, hyperDense middle cerebral artery, Age, Neurologic deficit score but also atrial fibrillation is predictive for symptomatic intracranial hemorrhage after intravenous recombinant tissue plasminogen activator.

Authors:  Sombat Muengtaweepongsa; Pornpoj Prapa-Anantachai; Pornpat A Dharmasaroja
Journal:  J Neurosci Rural Pract       Date:  2017 Jan-Mar

Review 8.  Clinical Variables and Genetic Risk Factors Associated with the Acute Outcome of Ischemic Stroke: A Systematic Review.

Authors:  Nuria P Torres-Aguila; Caty Carrera; Elena Muiño; Natalia Cullell; Jara Cárcel-Márquez; Cristina Gallego-Fabrega; Jonathan González-Sánchez; Alejandro Bustamante; Pilar Delgado; Laura Ibañez; Laura Heitsch; Jerzy Krupinski; Joan Montaner; Joan Martí-Fàbregas; Carlos Cruchaga; Jin-Moo Lee; Israel Fernandez-Cadenas
Journal:  J Stroke       Date:  2019-09-30       Impact factor: 6.967

9.  [Association of atrial fibrillation with hemorrhagic transformation after intravenous thrombolysis in patients with ischemic stroke].

Authors:  Anyang Tao; Zhimin Wang; Hongfang Chen; Dongjuan Xu; Haifang Hu; Chenglong Wu; Xiaoling Zhang; Xiaodong Ma; Yaxian Wang; Haitao Hu; Min Lou
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2019-05-25

10.  Comparison of Different Dosages of Alteplase in Atrial Fibrillation-Related Acute Ischemic Stroke After Intravenous Thrombolysis: A Nationwide, Multicenter, Prospective Cohort Study in Taiwan.

Authors:  Sheng-Feng Lin; Chien-Fu Chen; Han-Hwa Hu; Bo-Lin Ho; Chih-Hung Chen; Lung Chan; Huey-Juan Lin; Yu Sun; Yung-Yang Lin; Po-Lin Chen; Shinn-Kuang Lin; Cheng-Yu Wei; Yu-Te Lin; Jiunn-Tay Lee; A-Ching Chao
Journal:  J Am Heart Assoc       Date:  2022-01-20       Impact factor: 6.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.